Cleared Traditional

K010550 - VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428 (FDA 510(k) Clearance)

Apr 2001
Decision
57d
Days
Class 2
Risk

K010550 is an FDA 510(k) clearance for the VIDAS TOTAL PROSTATE SPECIFIC ANTIGEN (TPSA), MODEL 30 428. This device is classified as a Prostate-specific Antigen (psa) For Management Of Prostate Cancers (Class II - Special Controls, product code LTJ).

Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on April 24, 2001, 57 days after receiving the submission on February 26, 2001.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K010550 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 2001
Decision Date April 24, 2001
Days to Decision 57 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code LTJ — Prostate-specific Antigen (psa) For Management Of Prostate Cancers
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.6010